Why TransEnterix Is Skyrocketing Today
After the small-cap medical device company announced the Food and Drug Administration approval of its Senhance Surgical Robotic System, shares of TransEnterix (NYSEMKT: TRXC) jumped 75% as of 9:55 a.m. EDT on Monday.
TransEnterix's long-suffering bulls finally have reason to celebrate: The FDA has granted 510(k) clearance to its Senhance Surgical Robotic System.
Image source: TransEnterix.
Source: Fool.com